Case Report

Vogt-Koyanagi-Harada Syndrome and Ulcerative Colitis

Authors: Daniel G. Federman, MD, Jeffrey D. Kravetz, MD, Christopher B. Ruser, MD, Peter H. Judson, MD, Robert S. Kirsner, MD

Abstract

The Vogt-Koyanagi-Harada (VKH) syndrome is an uncommon disorder characterized by uveitis and neurologic and cutaneous abnormalities, including tinnitus, vertigo, headache, meningoencephalitis, vitiligo, alopecia, and poliosis. The VKH syndrome has been reported to occur in association with other autoimmune disorders. We report a case of a patient with severe ulcerative colitis who developed VKH syndrome. We postulate that the patient’s history of a traumatic brain injury might have been responsible for an abnormal “immunologic milieu” and the occurrence of ulcerative colitis, VKH syndrome, and severe reactive arthritis.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Jovic NS, Nesovic M, Vranjesevic DN, et al. The Vogt-Koyanagi-Harada syndrome: Association with autoimmune polyglandular syndrome type 1. Postgrad Med J 1996; 72: 495–497.
 
2. Jaggarao N, Voth D, Jacobsen J. The Vogt-Koyanagi-Harada syndrome: Association with hypothyroidism and diabetes mellitus. Postgrad Med J 1989; 65: 587–588.
 
3. Chi HI, Furue M, Ishibashi Y. Vogt-Koyanagi-Harada’s syndrome associated with Hashimoto’s thyroiditis. J Dermatol 1994; 21: 683–686.
 
4. Hettler DL, Levinson JB. A case of Vogt-Koyanagi-Harada syndrome. J Am Optom Assoc 1992; 63: 90–94.
 
5. Read RW, Rao NA, Cunningham ET. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol 2000; 11: 437–442.
 
6. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995; 39: 265–292.
 
7. Beniz J, Forster DJ, Lean JS, et al. Variations in clinical features of the Vogt-Koyanagi-Harada syndrome. Retina 1991; 11: 275–280.
 
8. Wong SS, Ng SK, Lee HM. Vogt-Koyanagi-Harada disease: Extensive vitiligo with prodromal generalized erythroderma. Dermatology 1999; 198: 65–68.
 
9. Rathinam SR, Namperumalsamy P, Nozik RA, et al. Vogt-Koyanagi-Harada syndrome after cutaneous injury. Ophthalmology 1999; 106: 635–638.
 
10. Hammer H. Cellular hypersensitivity to uveal pigment confirmed by leucocyte migration tests in sympathetic ophthalmitis and the Vogt-Koyanagi-Harada syndrome. Br J Ophthalmol 1974; 58: 773–776.
 
11. Matsuda H. Electron microscopic studies on Vogt-Koyanagi-Harada syndrome and sympathetic ophthalmia with special reference to the melanocyte [in Japanese]. Nippon Ganka Gakkai Zasshi 1970; 74: 1107–1112.
 
12. Maezawa N, Yano A, Taniguchi M, et al. The role of cytotoxic T lymphocytes in the pathogenesis of Vogt-Koyanagi-Harada disease. Ophthalmologica 1982; 185: 179–186.
 
13. Chuah SY, Lyne AJ, Dronfield MW. Vogt-Koyanagi-Harada syndrome, a rare association of Hodgkin’s disease. Postgrad Med J 1991; 67: 476–478.
 
14. Cipriani D, Landonio G, Canepari C. A case of Vogt-Koyanagi-Harada syndrome in a patient affected by Hodgkin’s disease. J Neurol 1989; 236: 303–304.
 
15. Iversen TH, Sverrisson T. Vogt-Koyanagi-Harada syndrome: A case report. Acta Ophthalmol (Copenh) 1986; 64: 235–238.
 
16. Ormantaev KS, Nadirov BN, Beliaev NN, et al. The effect of experimental craniocerebral trauma on cell-mediated and humoral immunity reactions [in Russian]. Zh Vopr Neirokhir Im N N Burdenko 1998; 4: 27–30.
 
17. Lisianyi MI, Rudenko VA, Hniedkova IO, et al. The characteristics of the immune disorders in primary and repeated craniocerebral trauma [in Ukrainian]. Fiziol Zh 1997; 43: 3–10.